| Financial Year |
March 31 2023 |
| Monetary Funds |
8,630,986,682.59 |
| Held-for-trading Financial Assets |
31,776,497.40 |
| Notes Receivable |
137,660,461.52 |
| Accounts Receivable |
907,935,873.58 |
| Advances to Suppliers |
161,620,282.46 |
| Other Receivables |
176,970,618.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
740,609,287.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
108,738,690.82 |
| Total Current Assets |
11,174,026,815.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,870,301.49 |
| Long-term Equity Investment |
2,338,343,429.15 |
| Investment Properties |
-- |
| Fixed Assetes |
19,398,744,662.33 |
| Under-construction Projects |
8,728,216,143.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,822,946,267.19 |
| R&D expenses |
4,472,927.79 |
| Goodwill |
126,964,616.45 |
| Long-Term Deferred and Prepaid Expenses |
147,646,173.09 |
| Deferred Income Tax Assets |
1,070,320,773.68 |
| Other Non-Current Assets |
241,249,305.93 |
| Sub-Total of Non-Current Assets |
37,436,820,490.35 |
| Total Assets |
48,610,847,305.37 |
| Short-Term Loans |
2,248,460,635.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
700,812,664.09 |
| Accounts Payable |
812,651,344.66 |
| Accounts Received In Advance |
4,702,648.59 |
| Employee Compensation Payable |
344,973,673.86 |
| Taxes Payable |
782,565,781.14 |
| Interest Payable |
-- |
| Dividend Payable |
97,517,601.92 |
| Other payables |
577,353,630.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,444,575,937.12 |
| Other Current Liabilities |
25,543,373.48 |
| Sub-Total of Current Liabilities |
7,278,922,383.85 |
| Long-term Loans |
8,566,558,136.53 |
| Bonds Payable |
5,194,953,333.28 |
| Long-Term Accounts Payable |
857,940,156.78 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
423,774,155.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,342,083,930.07 |
| Total Liabilities |
25,621,006,313.92 |
| Paid-In Capital(Or Share Stock) |
7,544,531,351.00 |
| Capital Surplus |
4,442,495,341.92 |
| Surplus Reserve |
914,659,440.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,834,998,335.38 |
| Minority Stockholder's Interest |
3,205,616,268.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
19,784,224,722.52 |
| Owner's Equity（Stockholder's Equity） |
22,989,840,991.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
48,610,847,305.37 |
